Paper23680930
Treatment of knee osteoarthritis with autologous mesenchymal stem cells: a pilot study.
Orozco L and 8 others. Transplantation, 2013. Cited by 337 papers, by iCite.
Cite this record
ConductScience Library. Treatment of knee osteoarthritis with autologous mesenchymal stem cells: a pilot study. Papers, record 23680930. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23680930
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Clinical Trial, Phase I, Clinical Trial, Phase II, Journal Article, Research Support, Non-U.S. Gov't
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Mesenchymal Stem Cells | Major topic |
| Osteoarthritis, Knee | Major topic |
| Adult | |
| Bone Marrow Cells | |
| Cartilage | |
| Female | |
| Humans | |
| Magnetic Resonance Imaging | |
| Male | |
| Middle Aged | |
| Pain Measurement | |
| Pilot Projects | |
| Quality of Life | |
| Treatment Outcome |
Source PubMed
Trials3
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT01183728 | Treatment of Knee Osteoarthritis With Autologous Mesenchymal Stem Cells | Results | ClinicalTrials.gov | |
| NCT01586312 | Treatment of Knee Osteoarthritis With Allogenic Mesenchymal Stem Cells | Background | ClinicalTrials.gov | |
| NCT05660824 | Effectiveness of Stromal Vascular Fraction (SVF) and Platelet -Rich Plasma (PRP) in Patients With Knee Osteoarthritis: Study Protocol for a Phase III, Prospective, Randomized, Controlled Multi-center Study. | Background | ClinicalTrials.gov |
Cited by211
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 337 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42668582 | Immune dysregulation in osteoarthritis: Mechanisms, biomarkers, and therapeutic opportunities. | J Transl Autoimmun | 2026 | https://conductscience.org/library/papers/42668582 | PubMed |
| 42626470 | Cord blood mesenchymal stromal cells combined with hyaluronic acid show symptom-modifying and potential disease-modifying effects in an equine osteoarthritis fetlock chip model. | Front Vet Sci | 2026 | https://conductscience.org/library/papers/42626470 | PubMed |
| 42077270 | Current and emerging therapies for knee osteoarthritis: From conventional approaches to machine learning and stem cell innovations. | Regen Ther | 2026 | https://conductscience.org/library/papers/42077270 | PubMed |
| 42006954 | Preclinical and early clinical safety of intra-articular spheroid adipose-derived stem cells for knee osteoarthritis: A translational study. | Osteoarthr Cartil Open | 2026 | https://conductscience.org/library/papers/42006954 | PubMed |
| 41836180 | Influence of Synovial Fluid Biochemical Markers on Clinical Outcomes Following Arthroscopic and Non-Arthroscopic Patients with Knee Osteoarthritis. | Orthop Rev (Pavia) | 2026 | https://conductscience.org/library/papers/41836180 | PubMed |
| 41598166 | Cell Surface Markers of Mesenchymal Stem Cells: Current Knowledge and Advances in Characterization Technologies. | Life (Basel) | 2025 | https://conductscience.org/library/papers/41598166 | PubMed |
| 41301106 | Intra-Articular Injection of Bone Marrow Concentrate for Patellofemoral Osteoarthritis Treatment: Preliminary Results Using a New Tibial Endplate Sample Under Ultrasound Guidance. | Bioengineering (Basel) | 2025 | https://conductscience.org/library/papers/41301106 | PubMed |
| 41163019 | Intra-articular delivery of allogeneic bone marrow derived mesenchymal stromal cells (BM-MSCs) for painful lumbar facet arthropathy: a phase I clinical trial. | Stem Cell Res Ther | 2025 | https://conductscience.org/library/papers/41163019 | PubMed |
| 41104102 | Mechanism and application of injectable hydrogel as carrier system in the treatment of osteoarthritis. | Front Bioeng Biotechnol | 2025 | https://conductscience.org/library/papers/41104102 | PubMed |
| 40951711 | Entering the era of living biopharmaceuticals for treating knee osteoarthritis: A systematic review and network meta-analysis. | World J Stem Cells | 2025 | https://conductscience.org/library/papers/40951711 | PubMed |
| 40943401 | Cartilage Regeneration Potential in Early Osteoarthritis of the Knee: A Prospective, Randomized, Open, and Blinded Endpoint Study Comparing Adipose-Derived Mesenchymal Stem Cell (ADSC) Therapy Versus Hyaluronic Acid. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40943401 | PubMed |
| 40721701 | Advancing osteoarthritis management: integrating new insights and addressing persistent roadblocks. | Inflammopharmacology | 2025 | https://conductscience.org/library/papers/40721701 | PubMed |
| 40566402 | Effects of Injections of Monocytes, Platelet-Rich Plasma, and Hyaluronic Acid in Adults with Knee Osteoarthritis: An Observational Study. | J Funct Morphol Kinesiol | 2025 | https://conductscience.org/library/papers/40566402 | PubMed |
| 40565232 | Overview of Cellular Therapeutics Clinical Trials: Advances, Challenges, and Future Directions. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40565232 | PubMed |
| 40565230 | Advances in Regenerative Therapies for Inflammatory Arthritis: Exploring the Potential of Mesenchymal Stem Cells and Extracellular Vesicles. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40565230 | PubMed |
| 40169165 | Stem cell injections for osteoarthritis of the knee. | Cochrane Database Syst Rev | 2025 | https://conductscience.org/library/papers/40169165 | PubMed |
| 40144957 | Efficacy of intra-articular injections for the treatment of osteoarthritis: A narrative review. | Osteoarthr Cartil Open | 2025 | https://conductscience.org/library/papers/40144957 | PubMed |
| 40002922 | A Narrative Review on Manufacturing Methods Employed in the Production of Mesenchymal Stromal Cells for Knee Osteoarthritis Therapy. | Biomedicines | 2025 | https://conductscience.org/library/papers/40002922 | PubMed |
| 39801757 | Mesenchymal stem cells for osteoarthritis: Recent advances in related cell therapy. | Bioeng Transl Med | 2025 | https://conductscience.org/library/papers/39801757 | PubMed |
| 39629035 | Efficacy and safety of mesenchymal stem cell injections for knee osteoarthritis: A systematic review and meta-analysis. | J Res Med Sci | 2024 | https://conductscience.org/library/papers/39629035 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23680930
GET https://conductscience.org/api/papers/v1/23680930/cited_by?page=2